Anesth Analg 2003;96:1789-1793
© 2003 International Anesthesia Research Society
OBSTETRIC ANESTHESIA
Nalbuphine Versus Ondansetron for Prevention of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery
Somrat Charuluxananan, MD MSc, FRCAT*, ,
Oranuch Kyokong, MD MSc, FRACT*, ,
Wanna Somboonviboon, MD FRCAT*,
Arunchai Narasethakamol, MD*, and
Pissamai Promlok, MD*
*Department of Anesthesiology and
Clinical Epidemiology Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Address correspondence and reprint requests to Charuluxananan Somrat, MD, Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Rama IV Rd., Pathumwan, Bangkok 10330, Thailand. Address e-mail to somratcu{at}hotmail.com
In this prospective, randomized, double-blinded study, we compared the prophylactic efficacy of nalbuphine and ondansetron for the prevention of intrathecal morphine-induced pruritus after cesarean delivery. Two-hundred-forty parturients were randomly allocated into four groups. The N-4 group, O-4 group, O-8 group, and placebo group received IV 4 mg of nalbuphine, 4 mg of ondansetron, 8 mg of ondansetron, and 4 mL of normal saline, respectively, immediately after the baby was delivered. In the postanesthesia care unit, we found that the severity of pruritus score in the four groups was significantly different (P < 0.001). The prophylactic success rate for pruritus of the N-4, O-4, O-8, and placebo groups was 20%, 13%, 12%, and 6%, respectively (P < 0.001). The pruritus score between N-4 and placebo and O-4 and placebo was significantly different (P < 0.001 and P = 0.006, respectively). Treatment for pruritus was requested by patients in 25%, 47%, 51%, and 72% of patients in the N-4, O-4, O-8, and placebo groups, respectively (P < 0.001). There were no differences among groups in nausea/vomiting score, pain score, sedation score, or shivering score at 4, 8, and 24 h after surgery. Nalbuphine and ondansetron are more effective than placebo for the prevention of intrathecal morphine-induced pruritus after cesarean delivery.
IMPLICATIONS: Nalbuphine and ondansetron are more effective than placebo for the prevention of intrathecal morphine-induced pruritus after cesarean delivery.
This article has been cited by other articles:

|
 |

|
 |
 
D. Tamdee, S. Charuluxananan, Y. Punjasawadwong, C. Tawichasri, J. Patumanond, and P. Sriprajittichai
A Randomized Controlled Trial of Pentazocine Versus Ondansetron for the Treatment of Intrathecal Morphine-Induced Pruritus in Patients Undergoing Cesarean Delivery
Anesth. Analg.,
November 1, 2009;
109(5):
1606 - 1611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. George, T. K. Allen, and A. S. Habib
Serotonin Receptor Antagonists for the Prevention and Treatment of Pruritus, Nausea, and Vomiting in Women Undergoing Cesarean Delivery with Intrathecal Morphine: A Systematic Review and Meta-Analysis
Anesth. Analg.,
July 1, 2009;
109(1):
174 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Bonnet, E. Marret, J. Josserand, and F. J. Mercier
Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review
Br. J. Anaesth.,
September 1, 2008;
101(3):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Sheen, S.-T. Ho, C.-H. Lee, Y.-C. Tsung, and F.-L. Chang
Preoperative Gabapentin Prevents Intrathecal Morphine-Induced Pruritus After Orthopedic Surgery
Anesth. Analg.,
June 1, 2008;
106(6):
1868 - 1872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Siddik-Sayyid, M. T. Aouad, S. K. Taha, M. S. Azar, M. A. Hakki, R. N. Kaddoum, V. G. Nasr, V. G. Yazbek, and A. S. Baraka
Does Ondansetron or Granisetron Prevent Subarachnoid Morphine-Induced Pruritus After Cesarean Delivery?
Anesth. Analg.,
February 1, 2007;
104(2):
421 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pirat, S. F. Tuncay, A. Torgay, S. Candan, and G. Arslan
Ondansetron, Orally Disintegrating Tablets Versus Intravenous Injection for Prevention of Intrathecal Morphine-Induced Nausea, Vomiting, and Pruritus in Young Males
Anesth. Analg.,
November 1, 2005;
101(5):
1330 - 1336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Iatrou, C. K. Dragoumanis, T. D. Vogiatzaki, G. I. Vretzakis, C. E. Simopoulos, and V. K. Dimitriou
Prophylactic Intravenous Ondansetron and Dolasetron in Intrathecal Morphine-Induced Pruritus: A Randomized, Double-Blinded, Placebo-Controlled Study
Anesth. Analg.,
November 1, 2005;
101(5):
1516 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Rathmell, T. R. Lair, and B. Nauman
The Role of Intrathecal Drugs in the Treatment of Acute Pain
Anesth. Analg.,
November 1, 2005;
101(5S_Suppl):
S30 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yazigi, V. Chalhoub, S. Madi-Jebara, F. Haddad, S. Charuluxananan, O. Kyokong, W. Somboonviboon, A. Narasethakamol, and P. Promlok
Ondansetron for Prevention of Intrathecal Opioids-Induced Pruritus, Nausea and Vomiting after Cesarean Delivery * Response
Anesth. Analg.,
January 1, 2004;
98(1):
264 - 264.
[Full Text]
[PDF]
|
 |
|
|